Healthcare · Diagnostics Research · NASDAQ
| Market cap | $12.69B |
|---|---|
| Trailing P/E | 14.2 |
| FCF yield | 6.6% |
| Revenue growth (YoY) | +0.8% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | -19.0% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
ICON Public Limited Company trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| John James | House | Sell | $1,001 - $15,000 | Sep 5, 2024 |
| Kevin Hern | House | Sell | $1,001 - $15,000 | Feb 1, 2023 |
| Kevin Hern | House | Buy | $1,001 - $15,000 | Jul 28, 2020 |
| Kevin Hern | House | Buy | $1,001 - $15,000 | Nov 8, 2019 |
| Thomas MacArthur | House | Sell | $1,001 - $15,000 | Jun 1, 2015 |